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Background
Natriuretic peptide receptors A (NPR-A) and B (NPR-B)
are transmembrane guanylyl cyclases that regulate blood
pressure, heart size and long bone growth. Unlike most
cell surface receptors that are desensitized by direct phos-
phorylation, phosphorylation of natriuretic peptide
receptors is essential for activation, and dephosphoryla-
tion causes their desensitization. While there are six and
five known phosphorylation sites within NPR-A and NPR-
B, respectively, studies in homologous sea urchin guanylyl
cyclase receptors indicate the presence of 15–17 moles of
phosphate per mole of receptor, suggesting additional
natriuretic peptide receptor phosphorylation sites remain
to be identified. The purpose of this study was to identify
novel natriuretic peptide receptor phosphorylation sites
by evaluating functional consequences of individual
glutamate or alanine substitutions of candidate residues
in order to mimic the effects of a phosphorylated or
dephosphorylated residue, respectively.
Methods and results
Highly conserved serine and threonine residues among
phosphorylated guanylyl cyclase receptors were mutated
individually to either alanine or glutamic acid. The activ-
ity of these mutant receptors was measured by evaluating
ligand-dependent guanylyl cyclase activities in mem-
branes from transfected HEK293 cells. Since all known
natriuretic peptide receptor phosphorylation sites are nec-
essary for maximal receptor activation, initial analysis of
putative sites assessed whether mutation glutamate and
alanine substitutions resulted in receptors with more or
less guanylyl cyclase activities, respectively.
Conclusion
Using a mutagenesis strategy to mimic phosphorylated
and dephosphorylated residues, we identified novel con-
served phosphorylation sites in NPR-A and NPR-B.
Mutant receptors containing alanine and glutamate sub-
stitutions at these sites produced less active and more
active receptors, respectively, consistent with phosphor-
ylation being required for ANP-dependent activation and
dephosphorylation mediating the desensitization of NPR-
A. These findings are currently being verified using tradi-
tional tryptic phosphopeptide mapping of metabolically
labelled receptors. This data will be discussed at the time
of presentation.
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